PIONEERINGNEUROSCIENCE.
Six years of foundational research across motor decoding, sensory restoration, and adaptive stimulation — published in Nature, Science, and Cell.
Research Reach.
// PUBLICATIONS // TRIALS // PARTNERS // IP
Seven Years of
Discovery.
From founding concept to first-in-human implant — each milestone built on the last.
Company Founded
NeuralTech established in San Francisco with $12M seed funding from Andreessen Horowitz and Deep Mind Ventures. Core team of 8 neuroscientists and engineers.
First In-Vitro Proof of Concept
Demonstrated 97% spike sorting accuracy on synthetic neural data using our proprietary transformer architecture — 4× better than prior state of the art.
NeuralLink Array v1.0
64-channel polymer electrode array cleared for acute animal studies. Published in Nature Neuroscience: "Ultra-flexible cortical probes with sub-cellular resolution."
First Human Implant
IRB-approved first-in-human study with ALS patient. Achieved 14ms decode latency for cursor control — enabling 40 words/minute typing via neural intent alone.
FDA Breakthrough Device
Received FDA Breakthrough Device Designation for motor BCI indication. Series B closed at $180M led by Google Ventures and Sequoia Capital.
CognitiveMesh Global Launch
Commercial launch of CognitiveMesh wireless hub across 14 clinical sites in North America and Europe. 312 patents filed. 147 peer-reviewed publications.
FeaturedPapers.
Collaborate on
the next breakthrough.
We actively seek research partnerships with institutions working on motor rehabilitation, sensory restoration, and brain-computer communication.